We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
Cap. Flow
-$468M
Cap. Flow %
-1.16%
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$178M
2
LYB icon
LyondellBasell Industries
LYB
+$133M
3
T icon
AT&T
T
+$124M
4
SWK icon
Stanley Black & Decker
SWK
+$101M
5
PFE icon
Pfizer
PFE
+$93.4M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$229M
2
GILD icon
Gilead Sciences
GILD
+$164M
3
AVGO icon
Broadcom
AVGO
+$149M
4
KEY icon
KeyCorp
KEY
+$145M
5
DRI icon
Darden Restaurants
DRI
+$125M

Sector Composition

Rank Sector Weight
1 Healthcare 20.22%
2 Technology 14.47%
3 Financials 10.84%
4 Industrials 9.01%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRBK
2026
DELISTED
Republic First Bancorp Inc
FRBK
$746 ﹤0.01%
829
-3,246
-80% -$3.71K
ALT icon
2027
Altimmune
ALT
$628M
$734 ﹤0.01%
208
-732
-78% -$3.29K
VRAY
2028
DELISTED
ViewRay, Inc.
VRAY
$734 ﹤0.01%
+2,085
New +$2.16K
TEAD
2029
Teads Holding Co
TEAD
$44.8M
$713 ﹤0.01%
+145
New +$638
ARL icon
2030
American Realty Investors
ARL
$260M
$697 ﹤0.01%
32
ACET icon
2031
Adicet Bio
ACET
$79.7M
$690 ﹤0.01%
+18
New +$1.59K
NKTX icon
2032
Nkarta
NKTX
$206M
$688 ﹤0.01%
+314
New +$1.38K
APRN
2033
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$683 ﹤0.01%
117
+55
+89% +$372
NGVT icon
2034
Ingevity
NGVT
$2.33B
$640 ﹤0.01%
11
-4,707
-100% -$282K
HOOK
2035
DELISTED
HOOKIPA Pharma
HOOK
$623 ﹤0.01%
71
-135
-66% -$1.5K
WYY icon
2036
WidePoint Corp
WYY
$112M
$618 ﹤0.01%
332
KRYS icon
2037
Krystal Biotech
KRYS
$9.97B
$587 ﹤0.01%
5
MTEM
2038
DELISTED
Molecular Templates, Inc.
MTEM
$584 ﹤0.01%
81
-170
-68% -$1.16K
NNI icon
2039
Nelnet
NNI
$4.56B
$579 ﹤0.01%
6
TZOO icon
2040
Travelzoo
TZOO
$57.3M
$576 ﹤0.01%
+73
New +$587
ITI
2041
DELISTED
Iteris, Inc.
ITI
$566 ﹤0.01%
+143
New +$638
SCPH
2042
DELISTED
scPharmaceuticals
SCPH
$560 ﹤0.01%
55
-206
-79% -$2.15K
LQDA icon
2043
Liquidia Corp
LQDA
$5.88B
$557 ﹤0.01%
+71
New +$552
CYT
2044
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$541 ﹤0.01%
208
YARW
2045
Yarrow Bioscience
YARW
$68.1M
$521 ﹤0.01%
3
OMER icon
2046
Omeros
OMER
$1.24B
$495 ﹤0.01%
+91
New +$531
AMTI
2047
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$493 ﹤0.01%
1,911
-210
-10% -$59
NVEC icon
2048
NVE Corp
NVEC
$473M
$487 ﹤0.01%
5
SIEN
2049
DELISTED
Sientra, Inc.
SIEN
$481 ﹤0.01%
164
-66
-29% -$117
STTK icon
2050
Shattuck Labs
STTK
$599M
$474 ﹤0.01%
152
-242
-61% -$702

Similar funds

Federated Hermes's Q2 2023 Portfolio in Review

As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
  • Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
  • Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
  • Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
  • Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
  • Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.